Amyotrophic Lateral Sclerosis (ALS)

ALS is a progressive disease that destroys the motor neurons in the nervous system. The vast majority of cases occur sporadically. Below is an overview of symptoms, diagnosis, and supportive treatment.

50s60s

Typical onset

Age 74

Risk peak

1.51.7×

M:F ratio

38 / 100k

US prevalence

Overview

What ALS does

Amyotrophic Lateral Sclerosis (ALS) is a progressive disease that destroys the motor neurons in the nervous system. The vast majority of cases occur sporadically. The mean onset of ALS occurs in the patients' 50's and 60's with increasing risk until the age of 74. Males are affected 1.51.7 times as often as females. The prevalence in the United States is 38 cases per 100,000 people.

Symptoms

How it presents

ALS usually begins with weakness in the arms and/or legs with progression in the affected area first, followed by more generalized weakness, atrophy, and twitching (fasciculations) of the muscles. When the motor neurons die, the associated muscles become weak, atrophied, and eventually die. Some patients develop cramping of the affected muscles.

Eventually, most muscular function is affected so patients can lose their ability to talk, swallow, and eventually to breathe. Some individuals with ALS will develop problems with processing information and memory, but in general patients will remain fully alert and aware. The sensations are also not involved.

The mean survival rate is 34 years, but about 410% of patients survive more than ten years. ALS is responsible for about 1 in 700 deaths in the United States. Death is usually peaceful with the patient dying in their sleep of respiratory failure.

Diagnosis

How it is identified

The diagnosis is a clinical one, usually with signs of involvement of the central and peripheral nervous system. The most accurate diagnostic test is an EMG and nerve conduction study. Muscle enzymes are frequently elevated in the serum, but they are less specific.

Treatment

Supportive care

There is no cure for ALS, but Riluzole may increase survival for a few months. It tends to be more effective in patients with bulbar onset (problems swallowing, speaking and/or breathing), in older patients, and when given early in the course of the disease.

On the whole, treatment is supportive, with physical therapy, assistive devices, respiratory support, and special feeding tools being helpful as the disease progresses.

This page is an educational summary and is not a substitute for professional medical advice. If you suspect ALS or have concerns about a loved one, please consult a neurologist for a proper evaluation.

Have questions about supportive care?

Reach out, we'll point you in the right direction.

All Conditions